Form SD - Specialized disclosure report:
SEC Accession No. 0001654954-17-005231
Filing Date
2017-05-31
Accepted
2017-05-31 17:07:43
Documents
1

Document Format Files

Seq Description Document Type Size
1 FORM SD navb_form-sd.htm SD 20939
  Complete submission text file 0001654954-17-005231.txt   22113
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

EIN.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SD | Act: 34 | File No.: 001-35076 | Film No.: 17881915
SIC: 2835 In Vitro & In Vivo Diagnostic Substances